Sensei Biotherapeutics Inc (NASDAQ: SNSE) is -18.64% lower on its value in year-to-date trading and has touched a low of $0.38 and a high of $1.94 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The SNSE stock was last observed hovering at around $0.62 in the last trading session, with the day’s loss setting it -0.06%.
Currently trading at $0.56, the stock is 9.98% and 3.29% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.98 million and changing -9.46% at the moment leaves the stock -30.41% off its SMA200. SNSE registered -10.63% loss for a year compared to 6-month loss of -43.23%. The firm has a 50-day simple moving average (SMA 50) of $0.54514 and a 200-day simple moving average (SMA200) of $0.809085.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 6.23% gain in the last 1 month and extending the period to 3 months gives it a -17.05%, and is 22.66% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 39.20% over the week and 16.76% over the month.
Sensei Biotherapeutics Inc (SNSE) has around 27 employees, a market worth around $14.16M and $0.00M in sales. Distance from 52-week low is 46.61% and -70.98% from its 52-week high. The company has generated returns on investments over the last 12 months (-54.16%).
Sensei Biotherapeutics Inc quarterly earnings per share for the current quarter are estimated at -0.31.The EPS is expected to grow by 8.24% this year
28.0 institutions hold shares in Sensei Biotherapeutics Inc (SNSE), with institutional investors hold 12.78% of the company’s shares. The shares outstanding are 25.03M, and float is at 16.54M with Short Float at 1.54%. Institutions hold 8.39% of the Float.
The top institutional shareholder in the company is IKARIAN CAPITAL, LLC with over 0.65 million shares valued at $0.4 million. The investor’s holdings represent 2.5949 of the SNSE Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 0.62 million shares valued at $0.38 million to account for 2.4702 of the shares outstanding. The other top investors are RENAISSANCE TECHNOLOGIES LLC which holds 0.22 million shares representing 0.8934 and valued at over $0.14 million, while BOOTHBAY FUND MANAGEMENT, LLC holds 0.69 of the shares totaling 0.17 million with a market value of $0.11 million.
